Skybiotech Healthcare Limited Share Price

Textiles

BSE: 512036 Small Cap ISIN: INE393H01016

As on 18 July 2026 at 06:27 IST

₹201.30

+ 7.05

(3.63%)

Sell Buy

Over 1 Month

39.85%

Over 6 Months

2.64%

Over 1 Year

15.94%

Over 3 Years

11.10%

Skybiotech Healthcare Limited Summary

Close ₹194.25

Open ₹195.30

High ₹195.30

Low ₹194.25

Volume 19

Net Turnover (in Cr) ₹0.00036

52Wk High ₹237.30

52Wk Low ₹116.45

52Wk High / Low

116.45

237.30

Skybiotech Healthcare Limited Fundamentals

Key Financial Data

Market Cap (in Cr) ₹37.20

EPS (TTM) -

Book Value (BV) 60.34

Div. Yield -

P/E (TTM) -626.61

Price/Book Value 3.22

Delivery % 100 %

Face Value 10

Key Ratios

PE Ratio 527.74

PB Ratio 2.66

EV to Sales -

PEG Ratio -5.49

ROA 0.51

ROE -0.44

Debt-Equity -

Net Profit Margin -

Operating Profit Margin -

Skybiotech Healthcare Limited Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025
Total Revenue	7.44
Total Expenses	9.86
Profit Before Tax	-2.43
Profit After Tax	-2.37
Operating Profit After Depreciation	-2.41

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025
Fixed Assets	12.03
Total Non Current Assets	18.18
Total Current Assets	1.92
Total Assets	20.10
Total Shareholder's Fund	8.99

Cash Flow

Particulars (in ₹ Cr.)	FY 2025
Net Cash From Operating Activities	-1.04
Net Cash Used In Investing Activities	-9.63
Net Cash Used In Financing Activities	1.24

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	0.18	2	0.05	0.02	0.02
Total Expenses	0.11	0.13	0.06	0.06	0.07
Profit Before Tax	0.08	1.88	-0.01	-0.04	-0.05
Profit After Tax	0.06	1.54	-0.01	-0.04	-0.05
Operating Profit After Depreciation	0.08	1.88	-0.01	-0.04	-0.05

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	0	0	0.01	0.01	0.01
Total Non Current Assets	12.48	2.93	4.04	4.36	3.68
Total Current Assets	0.15	8.60	0.02	0.02	0.02
Total Assets	12.62	11.53	4.06	4.37	3.70
Total Shareholder's Fund	11.78	10.83	3.49	3.72	3.22

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	0.30	-1.34	-0.37	0.61	1.28
Net Cash Used In Investing Activities	-9.30	3.63	0.38	-0.62	-1.27
Net Cash Used In Financing Activities	0.55	6.13	-	-	-

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	1.83	0.96	1.92	2.39	1.02
Total Expenses	2.71	1.40	2.14	2.31	2.10
Profit Before Tax	-0.85	-0.48	-0.30	-0.02	-1.18
Profit After Tax	-0.30	-0.48	-0.31	-0.02	-1.08
Operating Profit after Depreciation	-0.73	-0.36	-0.18	0.11	-1.26

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	-	-	-	-	-
Total Expenses	0.02	0.06	0.01	0.04	0.04
Profit Before Tax	-	-0.06	0.01	-0.01	-0.24
Profit After Tax	0.01	-0.06	0.01	-0.01	-0.20
Operating Profit after Depreciation	-	-0.06	0.01	-0.01	-0.24

Skybiotech Healthcare Limited Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 193.90

S2 193.55

S3 192.85

Pivot 194.60

R1 194.95

R2 195.65

R3 196

Moving Average

20 SMA 159.31

50 SMA 145.94

100 SMA 164.30

200 SMA 175.31

Skybiotech Healthcare Limited Corporate Actions

No available data

AGM Date: 30 Sep 2021

38Th AGM Of The Company Is Scheduled To Be Held On 30Th September 2021. Notice of Annual General Meeting along with Annual Report for the financial year 2020-2021. (As Per BSE Announcement dated on 06.09.2021) Consolidated Scrutinizer Report along with result as per Regulation 44 of Listing Regulation (LODR) 2015. (As Per BSE announcement Dated on 30.09.2021) Kapil Cotex Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here (As Per BSE Announcement Dated 01.10.2021) Combine Voting Result for Annual General Meeting held on 30th September 2021.(As Per BSE Announcement Dated on 11/27/2021 6:39:35 AM)

AGM Date: 30 Sep 2022

AGM 30/09/2022 Intimation of Book Closure pursuant to Regulation 42 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As per BSE Announcement Dated on 3/9/2022) SUBMISSION OF NEWSPAPER ADVERTISEMENT ABOUT DISPATCH OF ANNUAL REPORT 2021-2022 (As Per BSE Announcement Dated on 10.09.2022) CORPORATE ANNOUNCEMENT FOR OUTCOME OF 39TH ANNUAL GENERAL MEETING FOR THE FINANCIAL YEAR 2021-22 HELD ON FRIDAY, 30TH DAY OF SEPTEMBER, 2022 (As Per BSE Announcement dated on 30.09.2022)

AGM Date: 30 Sep 2023

Submission of Annual Report for the Financial Year 2022-23 Intimation of Book Closure pursuant to regulation 42 of the SEBI (LODR) Regulation, 2015. (As per BSE Announcement Dated on 06/09/2023) Outcome of 40th AGM for financial year 2023 (As per BSE Announcement Dated on 30/09/2023)

AGM Date: 30 Sep 2024

book closure for the 41st AGM to be held on 30.09.2024 Outcome of the Annual General Meeting of the Company held on 30th September,2024 at 11.30 AM (As Per Bse Announcement Dated on 30.09.2024) ADOPTION OF FINANCIAL STATEMENTS APPOINTMENT OF DIRECTOR (As Per BSE Announcement Dated on 02.10.2024)

AGM Date: 25 Sep 2025

Annual Report for Financial Year 2024-25 Outcome of 42nd Annual General Meeting of Kapil Cotex Limited (As Per BSE Announcement Dated on: 25/09/2025) Scrutinizer Report of AGM (As Per BSE Announcement Dated on:26.09.2025)

Skybiotech Healthcare Limited Peer Comparison

Company	Price	Market Cap (in Cr)
Grasim Industries Ltd	₹3,089.35	₹2,10,237.29
Vardhman Textiles Ltd	₹615.30	₹17,811.45
Welspun Living Ltd	₹135.65	₹13,010.90
Arvind Ltd	₹492.90	₹12,920.92
Trident Ltd	₹23.57	₹12,011.17

Skybiotech Healthcare Limited Top Mutal Funds Invested

No data available

Skybiotech Healthcare Limited News

Skybiotech Healthcare to discuss results

On 30 May 2026

27 May 2026, 03:11 pm

Skybiotech Healthcare to convene board meeting

On 14 February 2026

11 Feb 2026, 01:38 pm

Kapil Cotex to discuss results

On 14 November 2025

13 Nov 2025, 12:15 pm

Kapil Cotex to hold AGM

On 25 September 2025

04 Sep 2025, 04:04 pm

Kapil Cotex to hold board meeting

On 28 August 2025

23 Aug 2025, 05:11 pm

Skybiotech Healthcare Limited Stock Analysis

Annual revenue for Skybiotech Healthcare Limited decreased by 90.95% to ₹0.18 crore in FY 2025 from ₹2 crore in FY 2024.
Annual Net Profit for Skybiotech Healthcare Limited decreased by 96.11% to ₹0.06 crore in FY 2025 from ₹1.54 crore in FY 2024.
Promoter Shareholding in Skybiotech Healthcare Limited remains unchanged by 0.00% in the most recent quarter, from 63.48% in December 2025 to 63.48% in March 2026.
Skybiotech Healthcare Limited delivered a 1-year return of 15.94% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Skybiotech Healthcare Limited share price moved up by 3.63% from its previous close of INR ₹194.25. The latest Skybiotech Healthcare Limited share price is INR ₹201.30.
Skybiotech Healthcare Limited share price today has been at a low of 201.30 and a high of 203.45. Over the past 52 weeks, the Skybiotech Healthcare Limited share price has seen a low of 116.45 and a high of 237.30.